613 related articles for article (PubMed ID: 33936066)
1. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Lu H; Wu PF; Zhang W; Liao X
Front Immunol; 2021; 12():647588. PubMed ID: 33936066
[TBL] [Abstract][Full Text] [Related]
2. Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
Yuan S; Lin A; He QQ; Burgess S; Larsson SC
Int J Cardiol; 2020 Aug; 313():99-104. PubMed ID: 32223966
[TBL] [Abstract][Full Text] [Related]
3. Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation.
Yuan S; Li X; Lin A; Larsson SC
Semin Arthritis Rheum; 2022 Apr; 53():151958. PubMed ID: 35066242
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of circulating interleukins and risk of colorectal cancer: A bidirectional Mendelian randomization study.
Dong J; Jiang W; Zhang W; Hu R; Huang Z; Guo T; Du T; Jiang X
Environ Toxicol; 2024 May; 39(5):2706-2716. PubMed ID: 38240193
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosis.
Yuan S; Roos PM; Larsson SC
Eur J Neurol; 2020 Oct; 27(10):1913-1917. PubMed ID: 32441415
[TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin-27 is associated with the risk of chronic periodontitis and allergic rhinitis: A Mendelian randomization analysis.
Jiang N; Zhao J; Zhou C; Nan X
Autoimmunity; 2024 Dec; 57(1):2358070. PubMed ID: 38829359
[TBL] [Abstract][Full Text] [Related]
7. Circulating interleukins and risk of colorectal cancer: a Mendelian randomization study.
Jiang H; Liu Y; Zhou R; Feng Y; Yan L
Scand J Gastroenterol; 2023; 58(12):1466-1473. PubMed ID: 37525405
[TBL] [Abstract][Full Text] [Related]
8. A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.
Ge A; Sun Y; Kiker T; Zhou Y; Ye K
J Neuroimmunol; 2023 Jun; 379():578105. PubMed ID: 37207441
[TBL] [Abstract][Full Text] [Related]
9. Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.
Vandebergh M; Becelaere S; ; Dubois B; Goris A
Front Immunol; 2022; 13():834644. PubMed ID: 35386698
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study.
He D; Liu L; Shen D; Zou P; Cui L
Front Immunol; 2022; 13():867693. PubMed ID: 35619713
[TBL] [Abstract][Full Text] [Related]
11. Telomere length and multiple sclerosis: a Mendelian randomization study.
Ma Y; Wang M; Chen X; Ruan W; Yao J; Lian X
Int J Neurosci; 2024 Jun; 134(3):229-233. PubMed ID: 35791675
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Mokry LE; Ross S; Ahmad OS; Forgetta V; Smith GD; Goltzman D; Leong A; Greenwood CM; Thanassoulis G; Richards JB
PLoS Med; 2015 Aug; 12(8):e1001866. PubMed ID: 26305103
[TBL] [Abstract][Full Text] [Related]
13. Growth Factors and Their Roles in Multiple Sclerosis Risk.
Lu H; Wu PF; Ma DL; Zhang W; Sun M
Front Immunol; 2021; 12():768682. PubMed ID: 34745143
[TBL] [Abstract][Full Text] [Related]
14. Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study.
Tang Y; Liu W; Kong W; Zhang S; Zhu T
Front Immunol; 2023; 14():1077088. PubMed ID: 36845101
[TBL] [Abstract][Full Text] [Related]
15. Plasma circulating vitamin C levels and risk of multiple sclerosis: a two-sample Mendelian randomization analysis.
Peng H; Wu X; Wen Y; Lin J
Mult Scler Relat Disord; 2021 Nov; 56():103267. PubMed ID: 34610567
[TBL] [Abstract][Full Text] [Related]
16. Genetically predicted associations between circulating cytokines and autoimmune diseases: a bidirectional two-sample Mendelian randomization.
Jie J; Gong Y; Luo S; Yang X; Guo K
Front Immunol; 2024; 15():1404260. PubMed ID: 38860028
[TBL] [Abstract][Full Text] [Related]
17. Causal association of genetically determined circulating vitamin D metabolites and calcium with multiple sclerosis in participants of European descent.
Zhang Y; Liu H; Zhang H; Han Z; Wang T; Wang L; Liu G
Eur J Clin Nutr; 2023 Apr; 77(4):481-489. PubMed ID: 36635366
[TBL] [Abstract][Full Text] [Related]
18. Multiple Sclerosis and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
Yang F; Hu T; He K; Ying J; Cui H
Front Immunol; 2022; 13():861885. PubMed ID: 35371017
[TBL] [Abstract][Full Text] [Related]
19. Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis.
Meng C; Sun L; Shi J; Li Y; Gao J; Liu Y; Wei P; Yang Z; Yao H; Zhang Z
Int J Cancer; 2024 Jul; 155(1):159-171. PubMed ID: 38385833
[TBL] [Abstract][Full Text] [Related]
20. Large differences in adiponectin levels have no clear effect on multiple sclerosis risk: A Mendelian randomization study.
Devorak J; Mokry LE; Morris JA; Forgetta V; Davey Smith G; Sawcer S; Richards JB
Mult Scler; 2017 Oct; 23(11):1461-1468. PubMed ID: 27903934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
